Defining drivers of metastatic lung cancer. Read more about Defining drivers of metastatic lung cancer.
Spatial transcriptomic analysis of the lung cancer microenvironment. Read more about Spatial transcriptomic analysis of the lung cancer microenvironment.
Leveraging lung organoid models to improve lung cancer treatments. Read more about Leveraging lung organoid models to improve lung cancer treatments.
Identification of molecular prognostic and therapy resistance signatures in paediatric sarcomas. Read more about Identification of molecular prognostic and therapy resistance signatures in paediatric sarcomas.
Immune Enigma Unveiled - Pioneering Bioinformatic Pipelines for Non-Canonical HLA-Bound Peptide Exploration Read more about Immune Enigma Unveiled - Pioneering Bioinformatic Pipelines for Non-Canonical HLA-Bound Peptide Exploration
Modelling Type I Interferon-driven neuroinflammation in brain cells using patient-derived iPSCs Read more about Modelling Type I Interferon-driven neuroinflammation in brain cells using patient-derived iPSCs
Defining the mechanisms of chemotherapy resistance in childhood and adolescent osteosarcoma. Read more about Defining the mechanisms of chemotherapy resistance in childhood and adolescent osteosarcoma.
Modelling childhood leukemia for the development of new and improved therapeutic approaches Read more about Modelling childhood leukemia for the development of new and improved therapeutic approaches
Leveraging the innate immune system to improve lung cancer treatments Read more about Leveraging the innate immune system to improve lung cancer treatments
Essential virus sensors: investigating RNA receptors in infection Read more about Essential virus sensors: investigating RNA receptors in infection
